/

Menu
Trivia

Single-Dose Ebola Vaccine Reaches Testing Stage

posted: 04/09/15
by: Discovery.com Staff
Ebola virus illustration
DCI

Researchers from The University of Texas Medical Branch at Galveston have developed a single-dose Ebola vaccine. The vaccine is currently being tested in the Galveston National Laboratory, a Biosafety Level 4 laboratory.

The new vaccine is a Trojan horse of sorts; researchers injected a piece of the Ebola virus into a vesicular stomatitis virus, which successfully triggered a measurable immune response. Researchers then significantly weakened the Ebola virus in the vaccine in response to safety concerns.

"These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks," said Thomas Geisbert, UTMB professor of microbiology and immunology. "We are excited at the possibility of helping develop a way to stop this deadly disease. We have a lot of more work to accomplish but it's important to note that this is a big step."

Click here for more information from UTMB

YOU MIGHT ALSO LIKE

HELLO
About the blog:
DSCOVRD: The best of the web, covering space, technology, wildlife and more!
More on
MOST POPULAR